According to a TechSci Research report, the Exosome Therapeutics market is expected to grow significantly between 2024-2028. This growth is due to technological breakthroughs in exosome isolation and analysis for the treatment of chronic diseases such as cardiovascular diseases and cancer. Additionally, the demand for exosomes as a biomarker in research institutes and advancements in the development of genotype and phenotype-specific drug assays by pharmaceutical manufacturers are expected to enhance the demand for exosome therapeutics. The high therapeutic potential of exosomes in cancer diagnostics is also a major factor driving the growth of the market.
However, the high initial investment required for the development of better healthcare infrastructure may restrain the growth of the global exosome therapeutics market. The lack of diagnostic centers in developing regions and skilled professionals for handling instruments in research and diagnostic labs may also hamper market growth.
The global exosome therapeutics market is segmented by exosome type, source, therapy, application, end user, region, and competitive landscape. Based on therapy, the market can be segmented into Immunotherapy, Chemotherapy, and Gene Therapy. The immunotherapy segment is expected to drive market growth due to the growing adoption of new therapies for chronic diseases and government investment in new techniques.
Based on application, the market can be segmented into Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, and Others. The diagnostic segment is expected to propel market growth due to the rise in chronic diseases and demand for early diagnosis. The growing need for development and research activities is also driving demand for the global exosome therapeutics market.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Exosome Therapeutics Market” – https://www.techsciresearch.com/report/exosome-therapeutics-market/14415.html
Major companies are operating in global exosome therapeutics market:
- Aethlon Medical, Inc.-Exosome Sciences
- Aegle Therapeutics
- Anjarium Biosciences AG
- Exogenus Therapeutics SA
- Lonza Group
- Capricor Therapeutics, Inc.
- Avalon Globocare Corp
- Stem Cell Medicine Ltd.
- Evox Therapeutics Limited
- EV Therapeutics
In Feb 2022, Thermo Fisher Scientific signed an agreement with Bio-Techne Corporation which is a company that develops, manufactures, and sells life science reagents, instruments, and services. Under the agreement, Bio-Techne aimed to exclusively finish the design of and commercialize the ExoTRU kidney transplant rejection test developed by Exosome Diagnostics, a Bio-Techne brand. ExoTRU is a non-invasive multigene urine-based liquid biopsy test that offers crucial allograft health information to help clinician decision-making in handling kidney transplant patients and optimizing patient care.
Customers can also request for 10% free customization on this report.
“The North America region dominates the global exosome therapeutics market and is expected to maintain its dominance in the coming years due to the growing prevalence of chronic disorders such as cancer, diabetes, and autoimmune disorders across the region. Similarly, a growing number of product launches for exosome therapeutics is a major factor driving the growth of the market. Also, increasing the number of major key players along with the growing development of research activities in the pharmaceuticals and biopharmaceutical sector across the region is also propelling the growth of the market during the forecast period. Additionally, growing healthcare expenditure in the developing region and rise in the number of exosome diagnostic and therapeutic industries along with growing demand for molecular diagnosis is anticipated to boost the growth of the market over the years. However, the growth potential in the emerging economies for exosome therapeutics and the growing use of anti-aging therapy is expected to drive the growth of the exosome therapeutics market till 2028’ said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Exosome therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Exosome Type (Natural v/s Hybrid), By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others), By Therapy (Immunotherapy, Chemotherapy, Gene Therapy), By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region,” has evaluated the future growth potential of global exosome therapeutics market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global exosome therapeutics market.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=14415
Report Scope:
In this report, global exosome therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Exosome Therapeutics Market, By Type:
o Natural
o Hybrid
- Exosome Therapeutics Market, By Source:
o Mesenchymal Stem Cells
o Blood,
o Body Fluids,
o Others
- Exosome Therapeutics Market, By Therapy :
o Immunotherapy
o Chemotherapy
o Gene Therapy
- Exosome Therapeutics Market, By Application:
o Metabolic Disorders
o Oncology
o Cardiac Disorders
o Neurology
o Others
- Exosome Therapeutics Market, By End User:
o Hospitals & Clinics
o Academic & Research Institutions
o Others
- Exosome Therapeutics Market, By Region:
o North America
- United States
- Canada
- Mexico
o Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
o Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=14415
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]